BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38139284)

  • 21. Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner.
    Biliktu M; Senol SP; Temiz-Resitoglu M; Guden DS; Horat MF; Sahan-Firat S; Sevim S; Tunctan B
    Inflammopharmacology; 2020 Dec; 28(6):1509-1524. PubMed ID: 32128702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.
    Kim Y; Griffin JM; Nor MNM; Zhang J; Freestone PS; Danesh-Meyer HV; Rupenthal ID; Acosta M; Nicholson LFB; O'Carroll SJ; Green CR
    Neurotherapeutics; 2017 Oct; 14(4):1148-1165. PubMed ID: 28560708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
    Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
    Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice.
    Tonkin RS; Bowles C; Perera CJ; Keating BA; Makker PGS; Duffy SS; Lees JG; Tran C; Don AS; Fath T; Liu L; O'Carroll SJ; Nicholson LFB; Green CR; Gorrie C; Moalem-Taylor G
    Exp Neurol; 2018 Feb; 300():1-12. PubMed ID: 29055716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
    Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
    J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
    Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG
    Triantafyllakou I; Clemente N; Khetavat RK; Dianzani U; Tselios T
    Mol Pharm; 2022 Nov; 19(11):3795-3805. PubMed ID: 36098508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
    Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D
    Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
    Giralt M; Molinero A; Hidalgo J
    Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of p38 MAPK and Nrf2/HO-1/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of Clemastine in EAE rat model.
    Motawi TK; El-Maraghy SA; Kamel AS; Said SE; Kortam MA
    Biochem Pharmacol; 2023 Mar; 209():115435. PubMed ID: 36720356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
    Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
    Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases.
    Mat Nor MN; Rupenthal ID; Green CR; Acosta ML
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tibolone restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis.
    Mancino DNJ; Lima A; Roig P; García Segura LM; De Nicola AF; Garay LI
    J Neuroendocrinol; 2022 Jan; 34(1):e13078. PubMed ID: 34961984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Icariin ameliorates behavioral deficits and neuropathology in a mouse model of multiple sclerosis.
    Gao D; Zheng CC; Hao JP; Yang CC; Hu CY
    Brain Res; 2023 Apr; 1804():148267. PubMed ID: 36731819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Depression- and Anxiety-Like Behaviours in a Mouse Model of Relapsing-Remitting Multiple Sclerosis.
    Peres DS; Viero FT; Rodrigues P; de Barros Bernardes L; da Silva NAR; Lima IR; Martins G; Silveira PCL; de Amorim Ferreira M; Silva AM; Ferreira J; Trevisan G
    J Neuroimmune Pharmacol; 2023 Sep; 18(3):235-247. PubMed ID: 37526817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice.
    Dos Santos N; Novaes LS; Dragunas G; Rodrigues JR; Brandão W; Camarini R; Peron JPS; Munhoz CD
    Sci Rep; 2019 Apr; 9(1):6673. PubMed ID: 31040362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.